HBEGF and lung carcinoma: HB-EGF is upregulated in many cancers, including lung cancer; and increasingly, studies have confirmed that, in tumors, HB-EGF acts through binding and overactivating the EGFR pathway, generating signals for proliferation, differentiation, migration, and cell survival (20).